Lombard Odier Asset Management (Switzerland)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-120,479
| Closed | -$2.7M | – | 364 |
|
|
2022
Q3 | $2.7M | Sell |
120,479
-8,734
| -7% | -$196K | 0.23% | 99 |
|
|
2022
Q2 | $3.2M | Sell |
129,213
-42,112
| -25% | -$1.04M | 0.27% | 91 |
|
|
2022
Q1 | $6.64M | Sell |
171,325
-100,686
| -37% | -$3.9M | 0.52% | 56 |
|
|
2021
Q4 | $15.9M | Buy |
272,011
+145,101
| +114% | +$8.49M | 1.02% | 37 |
|
|
2021
Q3 | $7.52M | Buy |
+126,910
| New | +$7.52M | 0.47% | 71 |
|